<DOC>
	<DOCNO>NCT00928655</DOCNO>
	<brief_summary>The purpose study investigate effect nasal continuous positive airway pressure combination acetazolamide treatment sleep relate breathing disturbance patient obstructive sleep apnea syndrome live low altitude sojourn moderate altitude .</brief_summary>
	<brief_title>Continuous Positive Airway Pressure Acetazolamide Treat Sleep Apnea Syndrome Patients Altitude</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Obstructive sleep apnea syndrome , successfully CPAP therapy Residence low altitude ( &lt; 800 ) Obstructive apnea/hypopnea index &gt; 20/h complaint excessive daytime sleepiness introduction CPAP therapy &gt; 15 oxygen desaturations/h ( &gt; 3 % dip ) ambulatory nocturnal pulse oximetry perform end 4night period without CPAP Sleep disorder OSA More mild cardiovascular disease , unstable cardiovascular disease Any lung disease , pulmonary hypertension Chronic rhinitis Treatment drug affect respiratory center drive ( benzodiazepines sedative sleep induce drug , morphine codeine derivates ) , stimulant ( modafinil , methylphenidate , theophylline ) Internal , neurologic psychiatric disease interfere sleep quality Previous intolerance moderate low altitude ( &lt; 2600 ) Exposure altitudes &gt; 1500m &gt; 1 day within last 4 week study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>apnea</keyword>
	<keyword>sleep</keyword>
	<keyword>altitude</keyword>
	<keyword>hypoxia</keyword>
	<keyword>treatment</keyword>
	<keyword>CPAP</keyword>
</DOC>